Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Sarcoma 2Lymphoid 1

Conditions

Lymphoma, Follicular 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 8X-Rays 7Specimen Handling 7Phantoms, Imaging 6Nuclear Medicine Department, Hospital 6Biopsy 5ulixertinib 3trametinib 3palbociclib 3larotrectinib 3erdafitinib 3Temozolomide 3tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2ivosidenib 2ensartinib 2dabrafenib 2Vemurafenib 2Topotecan 2Paclitaxel 2Nivolumab 2Lomustine 2LY3023414 2Gemcitabine 2Filgrastim 2varlilumab 1trastuzumab biosimilar HLX02 1sonidegib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Gadolinium DTPA × Lymphoid × Clear all
NCT02278510 2017-03-31

Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
3 enrolled
CNSLymphoid

Glioma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡